ID ANXA3_HUMAN Reviewed; 323 AA. AC P12429; B2R9W6; Q6LET2; DT 01-OCT-1989, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 27-MAR-2024, entry version 217. DE RecName: Full=Annexin A3; DE AltName: Full=35-alpha calcimedin; DE AltName: Full=Annexin III; DE AltName: Full=Annexin-3; DE AltName: Full=Inositol 1,2-cyclic phosphate 2-phosphohydrolase; DE AltName: Full=Lipocortin III; DE AltName: Full=Placental anticoagulant protein III; DE Short=PAP-III; GN Name=ANXA3; Synonyms=ANX3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2968983; DOI=10.1016/s0021-9258(18)38041-4; RA Pepinsky R.B., Tizard R., Mattaliano R.J., Sinclair L.K., Miller G.T., RA Browning J.L., Chow E.P., Burne C., Huang K.-S., Pratt D., Wachter L., RA Hession C., Frey A.Z., Wallner B.P.; RT "Five distinct calcium and phospholipid binding proteins share homology RT with lipocortin I."; RL J. Biol. Chem. 263:10799-10811(1988). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=1830024; DOI=10.1016/0888-7543(91)90330-h; RA Tait J.F., Frankenberry D.A., Miao C.H., Killary A.M., Adler D.A., RA Disteche C.M.; RT "Chromosomal localization of the human annexin III (ANX3) gene."; RL Genomics 10:441-448(1991). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8276419; DOI=10.1006/geno.1993.1428; RA Tait J.F., Smith C., Xu L., Cookson B.T.; RT "Structure and polymorphisms of the human annexin III (ANX3) gene."; RL Genomics 18:79-86(1993). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Skeletal muscle; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Cervix; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP PROTEIN SEQUENCE OF 2-8. RC TISSUE=Platelet; RX PubMed=12665801; DOI=10.1038/nbt810; RA Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., RA Vandekerckhove J.; RT "Exploring proteomes and analyzing protein processing by mass spectrometric RT identification of sorted N-terminal peptides."; RL Nat. Biotechnol. 21:566-569(2003). RN [9] RP PROTEIN SEQUENCE OF 2-9; 40-48; 105-120; 155-163; 249-257; 264-274 AND RP 280-288, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND RP IDENTIFICATION BY MASS SPECTROMETRY. RC TISSUE=Colon carcinoma; RA Bienvenut W.V., Heiserich L., Gottlieb E.; RL Submitted (MAR-2008) to UniProtKB. RN [10] RP PROTEIN SEQUENCE OF 41-102 AND 126-138. RX PubMed=2159184; DOI=10.1126/science.2159184; RA Ross T.S., Tait J.F., Majerus P.W.; RT "Identity of inositol 1,2-cyclic phosphate 2-phosphohydrolase with RT lipocortin III."; RL Science 248:605-607(1990). RN [11] RP PROTEIN SEQUENCE OF 41-79; 85-88; 104-119; 126-150 AND 217-323. RX PubMed=2975506; DOI=10.1021/bi00417a011; RA Tait J.F., Sakata M., McMullen B.A., Miao C.H., Funakoshi T., RA Hendrickson L.E., Fujikawa K.; RT "Placental anticoagulant proteins: isolation and comparative RT characterization four members of the lipocortin family."; RL Biochemistry 27:6268-6276(1988). RN [12] RP PROTEIN SEQUENCE OF 42-55; 74-82; 105-126; 155-169; 177-209; 264-274 AND RP 305-315, AND CALCIUM-DEPENDENT BINDING TO PHOSPHOLIPIDS. RX PubMed=2138632; DOI=10.1172/jci114537; RA Ernst J.D., Hoye E., Blackwood R.A., Jaye D.; RT "Purification and characterization of an abundant cytosolic protein from RT human neutrophils that promotes Ca2(+)-dependent aggregation of isolated RT specific granules."; RL J. Clin. Invest. 85:1065-1071(1990). RN [13] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [14] RP X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS). RX PubMed=8639653; DOI=10.1021/bi952092o; RA Favier-Perron B., Lewit-Bentley A., Russo-Marie F.; RT "The high-resolution crystal structure of human annexin III shows subtle RT differences with annexin V."; RL Biochemistry 35:1740-1744(1996). RN [15] RP VARIANTS ASN-19; ASN-219; LEU-251 AND SER-291. RX PubMed=10391209; DOI=10.1038/10290; RA Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., RA Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., RA Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., RA Lander E.S.; RT "Characterization of single-nucleotide polymorphisms in coding regions of RT human genes."; RL Nat. Genet. 22:231-238(1999). RN [16] RP ERRATUM OF PUBMED:10391209. RA Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., RA Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., RA Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., RA Lander E.S.; RL Nat. Genet. 23:373-373(1999). CC -!- FUNCTION: Inhibitor of phospholipase A2, also possesses anti-coagulant CC properties. Also cleaves the cyclic bond of inositol 1,2-cyclic CC phosphate to form inositol 1-phosphate. CC -!- DOMAIN: A pair of annexin repeats may form one binding site for calcium CC and phospholipid. CC -!- SIMILARITY: Belongs to the annexin family. {ECO:0000255|PROSITE- CC ProRule:PRU01245, ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M20560; AAA59496.1; -; mRNA. DR EMBL; M63310; AAA52284.1; -; mRNA. DR EMBL; L20591; AAA16713.1; -; Genomic_DNA. DR EMBL; CR407648; CAG28576.1; -; mRNA. DR EMBL; AK313945; BAG36663.1; -; mRNA. DR EMBL; CH471057; EAX05822.1; -; Genomic_DNA. DR EMBL; BC000871; AAH00871.1; -; mRNA. DR CCDS; CCDS3584.1; -. DR PIR; A47658; LUHU3. DR RefSeq; NP_005130.1; NM_005139.2. DR PDB; 1AII; X-ray; 1.95 A; A=1-323. DR PDB; 1AXN; X-ray; 1.78 A; A=2-323. DR PDBsum; 1AII; -. DR PDBsum; 1AXN; -. DR AlphaFoldDB; P12429; -. DR SMR; P12429; -. DR BioGRID; 106803; 48. DR IntAct; P12429; 11. DR MINT; P12429; -. DR STRING; 9606.ENSP00000264908; -. DR DrugBank; DB09095; Difluocortolone. DR DrugBank; DB03994; Ethanolamine. DR DrugBank; DB00591; Fluocinolone acetonide. DR GlyGen; P12429; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P12429; -. DR PhosphoSitePlus; P12429; -. DR SwissPalm; P12429; -. DR BioMuta; ANXA3; -. DR DMDM; 113954; -. DR OGP; P12429; -. DR CPTAC; CPTAC-17; -. DR CPTAC; CPTAC-18; -. DR EPD; P12429; -. DR jPOST; P12429; -. DR MassIVE; P12429; -. DR MaxQB; P12429; -. DR PaxDb; 9606-ENSP00000264908; -. DR PeptideAtlas; P12429; -. DR PRIDE; P12429; -. DR ProteomicsDB; 52852; -. DR Antibodypedia; 2890; 689 antibodies from 35 providers. DR DNASU; 306; -. DR Ensembl; ENST00000264908.11; ENSP00000264908.6; ENSG00000138772.13. DR GeneID; 306; -. DR KEGG; hsa:306; -. DR MANE-Select; ENST00000264908.11; ENSP00000264908.6; NM_005139.3; NP_005130.1. DR UCSC; uc003hld.4; human. DR AGR; HGNC:541; -. DR CTD; 306; -. DR DisGeNET; 306; -. DR GeneCards; ANXA3; -. DR HGNC; HGNC:541; ANXA3. DR HPA; ENSG00000138772; Tissue enhanced (bone). DR MIM; 106490; gene. DR neXtProt; NX_P12429; -. DR OpenTargets; ENSG00000138772; -. DR PharmGKB; PA24831; -. DR VEuPathDB; HostDB:ENSG00000138772; -. DR eggNOG; KOG0819; Eukaryota. DR GeneTree; ENSGT00940000159174; -. DR HOGENOM; CLU_025300_0_0_1; -. DR InParanoid; P12429; -. DR OMA; KVKAIWA; -. DR OrthoDB; 1500773at2759; -. DR PhylomeDB; P12429; -. DR TreeFam; TF105452; -. DR PathwayCommons; P12429; -. DR SignaLink; P12429; -. DR SIGNOR; P12429; -. DR BioGRID-ORCS; 306; 17 hits in 1157 CRISPR screens. DR ChiTaRS; ANXA3; human. DR EvolutionaryTrace; P12429; -. DR GeneWiki; Annexin_A3; -. DR GenomeRNAi; 306; -. DR Pharos; P12429; Tbio. DR PRO; PR:P12429; -. DR Proteomes; UP000005640; Chromosome 4. DR RNAct; P12429; Protein. DR Bgee; ENSG00000138772; Expressed in right lung and 179 other cell types or tissues. DR ExpressionAtlas; P12429; baseline and differential. DR GO; GO:0030424; C:axon; IEA:Ensembl. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0030425; C:dendrite; IEA:Ensembl. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0016020; C:membrane; IDA:UniProtKB. DR GO; GO:0043025; C:neuronal cell body; IEA:Ensembl. DR GO; GO:0030670; C:phagocytic vesicle membrane; IDA:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0042581; C:specific granule; IDA:UniProtKB. DR GO; GO:0005509; F:calcium ion binding; IBA:GO_Central. DR GO; GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB. DR GO; GO:0048306; F:calcium-dependent protein binding; IPI:GO_Central. DR GO; GO:0019834; F:phospholipase A2 inhibitor activity; IEA:UniProtKB-KW. DR GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl. DR GO; GO:0042742; P:defense response to bacterium; IDA:UniProtKB. DR GO; GO:0021766; P:hippocampus development; IEA:Ensembl. DR GO; GO:0043312; P:neutrophil degranulation; IDA:UniProtKB. DR GO; GO:0006909; P:phagocytosis; IDA:UniProtKB. DR GO; GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB. DR GO; GO:0051054; P:positive regulation of DNA metabolic process; IEA:Ensembl. DR GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IDA:UniProtKB. DR GO; GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB. DR GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl. DR GO; GO:0070848; P:response to growth factor; IEA:Ensembl. DR Gene3D; 1.10.220.10; Annexin; 4. DR InterPro; IPR001464; Annexin. DR InterPro; IPR018502; Annexin_repeat. DR InterPro; IPR018252; Annexin_repeat_CS. DR InterPro; IPR037104; Annexin_sf. DR InterPro; IPR002390; ANX3. DR PANTHER; PTHR10502; ANNEXIN; 1. DR PANTHER; PTHR10502:SF25; ANNEXIN A3; 1. DR Pfam; PF00191; Annexin; 4. DR PRINTS; PR00196; ANNEXIN. DR PRINTS; PR00199; ANNEXINIII. DR SMART; SM00335; ANX; 4. DR SUPFAM; SSF47874; Annexin; 1. DR PROSITE; PS00223; ANNEXIN_1; 4. DR PROSITE; PS51897; ANNEXIN_2; 4. DR SWISS-2DPAGE; P12429; -. DR Genevisible; P12429; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Annexin; Calcium; Calcium/phospholipid-binding; KW Direct protein sequencing; Phospholipase A2 inhibitor; Phosphoprotein; KW Reference proteome; Repeat. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:12665801, ECO:0000269|Ref.9" FT CHAIN 2..323 FT /note="Annexin A3" FT /id="PRO_0000067477" FT REPEAT 18..89 FT /note="Annexin 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01245" FT REPEAT 90..161 FT /note="Annexin 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01245" FT REPEAT 173..245 FT /note="Annexin 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01245" FT REPEAT 249..320 FT /note="Annexin 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01245" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000269|Ref.9" FT MOD_RES 267 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P14669" FT VARIANT 19 FT /note="S -> N (in dbSNP:rs5951)" FT /evidence="ECO:0000269|PubMed:10391209" FT /id="VAR_013914" FT VARIANT 219 FT /note="I -> N (in dbSNP:rs5948)" FT /evidence="ECO:0000269|PubMed:10391209" FT /id="VAR_013915" FT VARIANT 251 FT /note="P -> L (in dbSNP:rs5949)" FT /evidence="ECO:0000269|PubMed:10391209" FT /id="VAR_013916" FT VARIANT 291 FT /note="F -> S (in dbSNP:rs5941)" FT /evidence="ECO:0000269|PubMed:10391209" FT /id="VAR_013917" FT CONFLICT 35 FT /note="G -> R (in Ref. 4; CAG28576)" FT /evidence="ECO:0000305" FT CONFLICT 146 FT /note="S -> G (in Ref. 11; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 294 FT /note="H -> R (in Ref. 11; AA sequence)" FT /evidence="ECO:0000305" FT HELIX 20..31 FT /evidence="ECO:0007829|PDB:1AXN" FT STRAND 32..35 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 38..45 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 50..64 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 68..75 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 78..88 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 91..103 FT /evidence="ECO:0007829|PDB:1AXN" FT STRAND 105..107 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 110..119 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 122..136 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 140..147 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 150..160 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 172..185 FT /evidence="ECO:0007829|PDB:1AXN" FT TURN 186..188 FT /evidence="ECO:0007829|PDB:1AXN" FT STRAND 189..191 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 194..203 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 206..220 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 224..231 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 234..262 FT /evidence="ECO:0007829|PDB:1AXN" FT STRAND 263..266 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 269..279 FT /evidence="ECO:0007829|PDB:1AXN" FT TURN 280..283 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 284..295 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 299..306 FT /evidence="ECO:0007829|PDB:1AXN" FT HELIX 309..319 FT /evidence="ECO:0007829|PDB:1AXN" SQ SEQUENCE 323 AA; 36375 MW; 4128C715491FC132 CRC64; MASIWVGHRG TVRDYPDFSP SVDAEAIQKA IRGIGTDEKM LISILTERSN AQRQLIVKEY QAAYGKELKD DLKGDLSGHF EHLMVALVTP PAVFDAKQLK KSMKGAGTNE DALIEILTTR TSRQMKDISQ AYYTVYKKSL GDDISSETSG DFRKALLTLA DGRRDESLKV DEHLAKQDAQ ILYKAGENRW GTDEDKFTEI LCLRSFPQLK LTFDEYRNIS QKDIVDSIKG ELSGHFEDLL LAIVNCVRNT PAFLAERLHR ALKGIGTDEF TLNRIMVSRS EIDLLDIRTE FKKHYGYSLY SAIKSDTSGD YEITLLKICG GDD //